A kinase inhibitor for eligible molecularly defined lung cancers or other solid tumors.
Profile scope: Repotrectinib. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Taste changes, bowel symptoms, headache, fatigue, swelling, weight gain, or tingling may occur.
Serious risks and warning signs
Neurological effects, lung or liver injury, muscle injury, fractures, and uric-acid-related problems need monitoring. New confusion, hallucinations, visual changes, breathlessness, jaundice, severe muscle weakness, or bone pain requires prompt assessment.
A question for your healthcare team
What neurological, liver, muscle, and bone checks apply, and which changes require immediate contact?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.